Véronique LADEVEZE | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Véronique LADEVEZE | Molecular Biology | Best Researcher Award

Dr at University of Poitiers, France

Dr. Véronique Ladevèze is an Assistant Professor in Biochemistry, Molecular Biology, and Genetics at the University of Poitiers, France. With over three decades of academic and scientific research experience, she is widely recognized for her work on membrane transporters and genetic mutations related to diseases such as cystic fibrosis and Alzheimer’s. She is affiliated with the MOVE laboratory (UR20296), where she investigates the molecular mechanisms of disease, particularly the roles of CFTR and SLC16a3 genes. Her expertise in alternative splicing and intron retention highlights her contributions to biomarker discovery for aging and neurodegenerative disorders. Dr. Ladevèze is also a committed educator and member of scientific advisory boards, actively mentoring students and contributing to biomedical education. She has participated in high-impact collaborative studies and serves on the Scientific Council of “Vaincre la Mucoviscidose,” supporting research and advocacy for cystic fibrosis. Her dedication to both science and society makes her a standout in her field.

profile

scopus

Education

Dr. Ladevèze has pursued a strong academic foundation in life sciences and genetics. She earned her Doctorate (Ph.D.) in Biochemistry from the University of Poitiers, where her research focused on molecular aspects of human diseases. She previously completed a DEA (Diplôme d’Études Approfondies) in Biomembranes, giving her a specialized foundation in membrane biology and protein transport. Her Master’s degree in Genetics from the University of Paris XI further deepened her knowledge in hereditary diseases, setting the groundwork for her later research into mutations and polymorphisms in key transport genes. She also holds credentials qualifying her to lead independent research from the University of Paris X. Her academic background spans the intersection of molecular biology, cell physiology, and genetic regulation, which informs both her teaching and innovative research on transport proteins and genetic biomarkers.

Experience

Dr. Véronique Ladevèze has extensive experience in both academic research and university-level teaching. She began her academic career as a Lecturer at the University of Tours before joining the University of Poitiers, where she currently serves as Assistant Professor. Over the past 30+ years, she has specialized in studying disease-related membrane transporters such as CFTR (cystic fibrosis) and SLC16a3 (Alzheimer’s and aging). Her experience includes advanced molecular techniques in genomics, splicing analysis, and mutation profiling. She has collaborated with major French and international institutions and has served as a scientific expert for “Vaincre la Mucoviscidose,” a leading organization combating cystic fibrosis. She contributes actively to educational programs at both undergraduate and postgraduate levels and is involved in supervising research students. Her interdisciplinary work bridges laboratory discovery with translational insights into human disease.

Awards and Honors

Dr. Ladevèze has received significant academic and professional recognition throughout her career. She was awarded the title “Hors Classe” with exceptional step status in 2017—an honor conferred in the French academic system for distinguished service and scholarly excellence. She has been a Scientific Council Member of “Vaincre la Mucoviscidose” from 2018 to 2024, where she plays a pivotal advisory role in guiding research direction on cystic fibrosis. Her expertise is frequently sought for evaluations and scientific panels, underscoring her leadership in the biomedical research community. In addition to peer-reviewed publications, she contributes to science communication and public health awareness, especially in the area of genetic diseases. These honors reflect her consistent dedication to advancing research and improving clinical understanding of complex genetic disorders through her pioneering work in transporter biology and splicing mechanisms.

Research Focus

Dr. Ladevèze’s research centers on membrane transporters, specifically the ABC (e.g., CFTR) and SLC (e.g., SLC16a3/MCT4) protein families. Her early work contributed to understanding how rare mutations in CFTR affect protein function and disease severity in cystic fibrosis, one of the most common rare genetic disorders. More recently, her focus has shifted to alternative splicing and intron retention, particularly in the SLC16a3 gene, which may play a role in Alzheimer’s disease and brain aging. She studies how these molecular changes act as potential biomarkers of neurodegenerative stress and dysfunction. Using models like APP/PS1 mice, she explores how transcript variants influence the expression of MCT4 in aging brain tissue. Her interdisciplinary research integrates molecular genetics, neuroscience, and cellular biology, contributing valuable insights into both rare and complex diseases. Her work is highly translational, with implications for diagnostics and personalized medicine.

Skills

Dr. Véronique Ladevèze possesses a comprehensive skill set that bridges advanced research, teaching, and collaboration. As a scientific leader, she has coordinated projects focused on gene transporters, guiding interdisciplinary teams in exploring disease mechanisms. Her expertise in molecular biology and genetics includes mutation analysis, splicing regulation, RT-PCR, and gene expression profiling, particularly applied to cystic fibrosis and neurodegenerative diseases. Fluent in both French and English, she engages effectively in international research collaborations. In academia, she teaches undergraduate and master’s courses in biohealth and actively mentors students in laboratory research. Dr. Ladevèze has a strong record of publishing in peer-reviewed journals and contributes regularly to academic discussions and conferences. She also serves on scientific advisory boards, providing critical peer evaluations and promoting high research standards. Her focus on disease-driven investigation, particularly involving aging and Alzheimer’s biomarkers, highlights her commitment to impactful, translational science that addresses complex medical challenges.

Publications

  • CFTR mutation combinations producing frequent complex alleles with different clinical and functional outcomes
    Authors: El-Seedy A., Girodonne A., Norez C., Pajato J., Pasquet M.-C., de Becdelievre A., Bienvenu T., des Georges M., Cabet F., Halau G., Bieth E., Blayau M., Becq F., Kitzis A., Fanen P., Ladevèze V.
    Year: 2012
    Journal: Human Mutation, Volume 33, Issue 11, Pages 1557–1565
    Citations: 4

  • Identification of Intron Retention in the Slc16a3 Gene Transcript Encoding the Transporter MCT4 in the Brain of Aged and Alzheimer-Disease Model (APPswePS1dE9) Mice
    Authors: El-Seedy A., Pellerin L., Page G., Ladevèze V.
    Year: 2023
    Journal: Genes, Volume 14, Issue 10, Article 1949
    Citations: 4

Conclusion

Dr. Véronique Ladevèze is a highly qualified candidate for a Best Researcher Award, especially within a biomedical or genetic research context. Her long-standing commitment to impactful, disease-oriented research and academic mentorship strongly supports her candidacy. While some improvements in international visibility and external funding could strengthen her profile further, her body of work already demonstrates excellence in research, innovation, and service to the scientific community.

Chunjie Gong | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Chunjie Gong | Molecular Biology | Best Researcher Award

Professor at Hubei University of Technology, China

Dr. Chunjie Gong is an accomplished researcher and educator specializing in bioresource technology, microbial bioconversion, and green energy solutions. With a career spanning over two decades, Dr. Gong has made significant contributions to the fields of microbial catalysis, enzymology, and lignocellulosic biomass valorization. His work integrates cutting-edge biotechnology with industrial sustainability, leading to impactful innovations in biofuel production and bioproducts synthesis. As a dedicated academic, he balances research excellence with pedagogical commitment, fostering both scientific progress and student development.

profile

scopus

Education

Dr. Gong began his academic journey at Northeast Normal University, earning a bachelor’s degree in 2002 and subsequently completing his master’s degree in 2008. Driven by a passion for advanced scientific inquiry, he pursued a Ph.D. at Kyoto University, Japan, completing his doctoral studies in 2013. During his doctoral program, he developed a strong foundation in microbiology, biochemical engineering, and environmental biotechnology. This cross-national education enabled him to blend Eastern and Western research methodologies, broadening his academic perspective and technical repertoire.

Experience

Following his master’s graduation, Dr. Gong began his teaching career at Changchun Vocational and Technical College, before serving as an instructor at the Preparatory School for Chinese Students to Japan. His early academic service was complemented by postgraduate and postdoctoral research at Kyoto University, where he delved into microbial metabolism and fermentation engineering. Since 2014, Dr. Gong has been a faculty member at Hubei University of Technology, contributing to both research and teaching. His international engagement continued with a visiting scholar tenure at Kyoto University from 2022 to 2023. Across these roles, Dr. Gong has demonstrated a consistent trajectory of scholarly leadership and mentorship.

Research Interest

Dr. Gong’s research focuses on microbial biotechnology, with a particular emphasis on the bioconversion of agricultural and industrial waste into high-value biofuels and biochemicals. His interests encompass enzymatic catalysis, metabolic pathway engineering, and solid-liquid fermentation systems. He has worked extensively on genetically engineering microbial strains for enhanced production of ethanol, hydrogen, and organic acids. Dr. Gong is also involved in developing integrated bioprocesses for the transformation of lignocellulosic biomass and kitchen waste into eco-friendly fertilizers and bioenergy. His work directly addresses critical challenges in sustainable development and environmental remediation.

Awards

In recognition of his academic excellence and societal contributions, Dr. Gong received the prestigious Japan Ministry of Education Scholarship (2009–2013) and the China Scholarship Council Fellowship (2022–2023). He was also honored as an excellent member of the Seventh (2018) and Ninth (2021) Doctor Service Groups in Hubei Province, awards granted by the Organization Department of the Hubei Provincial Party Committee and the Communist Youth League. These accolades highlight both his scientific merit and his dedication to community service and rural development.

Publications

Dr. Gong has authored numerous influential articles in high-impact journals. Selected recent publications include:

Li et al., 2024, “Production of acetic acid from wheat bran,” Bioresource Technology, IF 11.4 – Cited by 5 articles.

Zhang et al., 2024, “Co-production of ferulic acid and p-coumaric acid,” Journal of Cleaner Production, IF 11.1 – Cited by 4 articles.

Xue et al., 2024, “Ethyl lactate biosynthesis via aerobic-anaerobic cascade,” Cellulose, IF 5.7 – Cited by 3 articles.

Cao et al., 2023, “Ferulic acid from wheat bran using cold-adapted carboxylesterase,” Bioresource Technology, IF 11.889 – Cited by 7 articles.

Fang et al., 2023, “Concurrent production of ferulic acid and glucose,” Bioresource Technology, IF 11.889 – Cited by 6 articles.

Zhang et al., 2023, “Genetic engineering for biohydrogen production,” iScience, IF 6.107 – Cited by 3 articles.

Gong et al., 2022, “Ethanol production from lignocellulose waste,” Bioresource Technology, IF 11.889 – Cited by 8 articles.

These publications demonstrate Dr. Gong’s role as both a leading researcher and frequent corresponding author, confirming his leadership in experimental design and manuscript preparation.

Conclusion

Dr. Chunjie Gong exemplifies the ideal candidate for the Best Researcher Award. His multidisciplinary background, sustained high-quality research output, international collaborations, and impactful contributions to environmental biotechnology position him as a leader in his field. His ongoing projects and patent portfolio further reinforce his relevance to both academic innovation and practical applications. He stands out as a visionary scholar making meaningful advancements in sustainable science.

Congguang Shi | Molecular Biology | Excellence in Research Award

Published on by Medical Lab Scientist

Mr. Congguang Shi | Molecular Biology | Excellence in Research Award

associate researcher at Zhejiang Academy of Forestry, China

Dr. Congguang Shi currently serves as an associate researcher at the Zhejiang Academy of Forestry Sciences, where he has significantly contributed to the genetic improvement of forest trees and the protection of extremely small populations. With over a decade of expertise in forestry research, he has emerged as a key scientific figure in developing conservation strategies and breeding techniques tailored to regional biodiversity. His dedication to applied forestry science and his active participation in national and provincial research programs underscore his leadership in sustainable forestry practices and innovation in plant genetic resources.

profile

scopus

Education

Dr. Shi’s academic foundation is rooted in life sciences and plant genetics, which laid the groundwork for his specialized career in forestry research. While the document does not list formal educational credentials, his extensive publication record, project leadership, and patent contributions indicate rigorous academic training, likely at the graduate and doctoral levels, with a focus on forestry biology, molecular breeding, and environmental sustainability. His scientific literacy across disciplines, including molecular biology, toxicology, and agronomy, reflects an interdisciplinary education tailored to applied forestry science.

Experience

Dr. Shi has presided over two public welfare research projects funded by the Zhejiang Provincial Department of Science and Technology. Additionally, he has played a central role in over 20 significant national and ministerial projects, including the National 863 Program and key topics under the Ministry of Forestry’s 948 Project. His experience spans from molecular mechanisms of oil formation in oilseed crops to hormone regulation in tree species, and from field cultivation trials to genetic conservation strategies. This comprehensive range of responsibilities has equipped him with practical, technical, and scientific capabilities across forestry biotechnology and conservation ecology.

Research Interests

Dr. Shi’s primary research interests include forest tree genetic improvement, especially of indigenous and economically valuable species, and the conservation of extremely small populations such as Styrax zhejiangensis and endangered marsh plants. He is also deeply involved in the biochemical and genetic analysis of seed oil traits, propagation biology, and the application of plant growth regulators to enhance reproductive traits in species such as Ginkgo biloba. His interdisciplinary approach bridges classical breeding with molecular biology to promote genetic diversity, bioenergy production, and the sustainable use of rare forest resources.

Awards

Dr. Shi has received notable accolades recognizing his collaborative scientific achievements. In 2015, he contributed as the fifth author to a project on biodiesel-oriented cultivation of high-yield Styrax species, which won the Second Prize of the Zhejiang Provincial Forestry Department Science and Technology Award. That same year, he was also the eighth contributor to a project on the preservation and cultivation of valuable Phoebe germplasm resources, which earned the same award. In 2016, he was recognized as the ninth contributor to a project on the molecular mechanisms of fatty acid formation in cruciferous oilseeds, receiving the second prize in Natural Science from the Ministry of Education.

Publications

Dr. Shi has authored 28 academic papers, including 11 as first or corresponding author. Selected key publications include:

Shi, C. et al. (2013). Changes in oil content and fatty acid composition during seed maturation in Styrax tonkinensis. Journal of Zhejiang A&F University, 30(3):372–378. [Cited by multiple studies on seed biochemistry]

Shi, C. et al. (2014). Refinement and toxicological evaluation of Styrax seed oil. Journal of Chinese Institute of Food Science and Technology, 14(5):192–201.

Shi, C. et al. (2017). Karyotype analysis of root tips from three Styrax species. Zhejiang Forestry Science and Technology, 37(3):23–27.

Shi, C. et al. (2019). Effects of root pruning and fertilization on Ginkgo biloba growth. Zhejiang Forestry Science and Technology, 39(2):69–74.

Shi, C. et al. (2020). Influence of exogenous hormones on flowering and gene expression in female Ginkgo trees. Zhejiang Forestry Science and Technology, 40(2):1–8.

Shi, C. et al. (2021). Nutritional components and acute oral toxicity of Ranalisma rostratum. Journal of Zhejiang A&F University, 38(X):1–8.

Yang, J., Shi, C., et al. (2021). Efficient in-vitro propagation of endangered Ranalisma rostratum. Pakistan Journal of Botany, 53(3):1037–1043.

Conclusion

Dr. Congguang Shi exemplifies the spirit of the “Excellence in Research Award” through his commitment to high-impact research, interdisciplinary collaboration, and conservation of botanical diversity. His research outcomes not only advance scientific understanding but also provide practical solutions to forestry challenges. With a prolific publication record, active patent contributions, and national recognition, Dr. Shi stands as a deserving candidate for this distinguished honor.

Dilek Gungor | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Mr. Dilek Gungor | Biochemistry | Best Researcher Award

Postdoctoral Researcher at Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey

Dilek Güngör is a researcher in forensic biochemistry and nanomedicine with a strong academic background and multidisciplinary experience. Her work focuses on innovative drug delivery systems, particularly in combating antimicrobial resistance. Through research roles at both national institutions and internationally renowned universities, she has established a profile marked by scientific curiosity, methodical rigor, and impactful contributions to pharmaceutical and forensic sciences.

profile

orcid

Education

Dilek completed her Ph.D. in Nanotechnology and Nanomedicine at Hacettepe University in December 2024, where she focused on liposome-based co-delivery systems for antimicrobial peptides and antibiotics. Her doctoral studies included an international research stint at Rutgers University in the U.S., supported by TÜBİTAK 2214/A. She earned her M.Sc. in Biochemistry (Pharmacy) from Gazi University in February 2018 and her B.Sc. in Biochemistry with a specialization in Biotechnology from Ege University in June 2009. Her academic formation reflects a consistent commitment to molecular and pharmaceutical sciences, with thesis work investigating gene expressions in cancer and novel therapeutic delivery platforms.

Experience

Dilek has served as a Research Assistant at the Turkish National Police Academy across several departments since 2014, currently contributing to the Forensic Science Department. Between 2022 and 2023, she was a Visiting Scholar at Rutgers University’s Center for Dermal Research, deepening her expertise in transdermal drug delivery systems. Her experience spans over a decade of applied biochemical research, including project leadership and interdisciplinary collaboration. She has demonstrated a capacity to work at the intersection of academic research and forensic application, contributing to both scientific advancement and public service.

Research Interest

Her research interests include nanomedicine, forensic toxicology, and dermal drug delivery systems. She is particularly engaged in designing liposome-based systems for co-delivery of antimicrobial agents, with an emphasis on reducing antimicrobial resistance. Additionally, she investigates molecular markers in cancer diagnostics and has an emerging interest in biosensor technologies for forensic and clinical applications. Her research is characterized by translational intent, targeting real-world medical and forensic challenges through molecular innovation.

Awards

Dilek has been recognized with a TÜBİTAK 2214-A International Research Fellowship, allowing her to pursue advanced pharmaceutical research abroad. Earlier in her career, she contributed to a TÜBİTAK 2209-A project on biosensor development during her undergraduate studies. These fellowships underscore both her scientific promise and her capacity to lead cutting-edge research in nationally and internationally competitive contexts.

Publications

Among her notable works, her 2025 article, “Co-delivery of Azithromycin and Nisin through liposomes for skin infection to reduce antimicrobial drug resistance,” was published in the International Journal of Pharmaceutics and has begun receiving citations for its innovative approach to antimicrobial therapy. In 2024, she co-authored “Evaluation of the interactions between human stratum corneum and liposome formulations using QCM-D” in the Journal of Drug Delivery Science and Technology, highlighting her proficiency in advanced instrumentation. In 2020, she published two significant papers in the European Journal of Breast Health and the Athens Journal of Health and Medical Sciences, focusing on glutathione-related enzymes in breast cancer subtypes. Her earlier publication, “Sentetik uyuşturucular: Amfetamin örneği,” appeared in the Güvenlik Çalışmaları Dergisi in 2018 and reflects her forensic research contributions. Her most cited article is the 2025 IJPharm paper on liposomal drug delivery for antimicrobial resistance, which is increasingly referenced in pharmaceutical and clinical research circles.

Conclusion

Dr. Dilek Güngör exemplifies the qualities of an outstanding researcher through her interdisciplinary education, impactful publications, technical mastery, and sustained commitment to scientific advancement. Her ability to bridge the gap between laboratory research and real-world application, particularly in the areas of antimicrobial resistance and diagnostics, positions her as an ideal recipient of the Best Researcher Award. Her trajectory reflects both depth and breadth of expertise, making her a valuable asset to the scientific community at large

Irene Gómez | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Irene Gómez | Molecular Biology | Best Researcher Award

Investigador Postdoctoral at Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Spain

Irene Gómez Delgado is a passionate and highly skilled postdoctoral researcher working at the Health Research Foundation of Clínico San Carlos Hospital, where she specializes in biomedicine, medical microbiology, and environmental risks. She has shown exceptional dedication to scientific discovery, focusing on the genetic and molecular basis of complex diseases, particularly in the area of immunology and nephrology. Irene’s collaborative spirit, commitment to rigorous methodology, and enthusiasm for public science engagement have marked her as an emerging leader in her field.

profile

orcid

Education

Irene Gómez Delgado’s academic journey reflects both excellence and depth, beginning with her Bachelor’s Degree in Biology from Universidad Complutense de Madrid, earned in 2016. She continued her academic pursuit with a Master’s Degree in Immunology Research from the same university in 2017, equipping her with advanced knowledge of immune system mechanisms. She culminated her formal education by earning a PhD in Molecular Bioscience at Universidad Autónoma de Madrid in 2022, where she developed a strong foundation in molecular biology, genetic research, and experimental design, all of which continue to influence her contributions to biomedical science.

Experience

Irene has steadily advanced her scientific career through key research roles, beginning as a predoctoral researcher at the Health Research Foundation of La Paz University Hospital from 2017 to 2022, where she gained comprehensive experience in molecular biology, laboratory supervision, and project execution. Since 2022, she has been working as a postdoctoral researcher at Clínico San Carlos Hospital’s Laboratory of Genetic and Molecular Basis of Complex Diseases. Alongside her research, Irene has co-directed Master’s Final Projects and supervised undergraduate students and laboratory technicians, showing strong leadership and mentorship capabilities.

Research Interest

Irene’s research interests lie primarily in understanding the molecular and genetic mechanisms underlying immunological and nephrological diseases. Her scientific focus includes studying complement system dysregulation, genetic variants related to immune system proteins, and mitochondrial alterations in immune cells. Her work also extends to infectious disease complications, including severe COVID-19 immune responses, making her research impactful for both rare disease understanding and global health challenges.

Award

Irene Gómez Delgado has been recognized for her scientific achievements through multiple awards. In 2023, she was honored with the Extraordinary Doctorate Award by Universidad Autónoma de Madrid, celebrating the outstanding quality and impact of her doctoral work. She also received the Poster Communication Award from the European Complement Network in 2022 for her contribution at the 18th European Meeting on Complement in Human Disease held in Bern, Switzerland. These awards highlight her scientific excellence and growing reputation in the immunology and nephrology research communities.

Publication

Dr. Gómez Delgado has co-authored several peer-reviewed scientific articles that contribute to the advancement of biomedical research.

Long term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19 — published in 2025 in Cell Biology and Toxicology.

Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production — published in 2024 in International Journal of Molecular Sciences.

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome — published in 2021 in Frontiers in Immunology.

Low factor H-related 5 levels contribute to infection-triggered haemolytic uraemic syndrome and membranoproliferative glomerulonephritis — published in 2021 in Clinical Kidney Journal.

High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B — published in 2018 in Frontiers in Immunology.

Contribution of functional and quantitative genetic variants of Complement Factor H and Factor H-Related (FHR) proteins on renal pathology — published in 2022 in Nefrología.

Altered expression of FHR-1 and FHR-2 glycoforms in IgA nephropathy patients — published in 2024 in European Journal of Immunology (Meeting Abstract).

Conclusion

Dr. Irene Gómez Delgado exemplifies the qualities of a leading researcher through her pioneering contributions to immunology and molecular medicine, her active engagement in scientific dissemination, and her commitment to mentorship and collaborative research. Her career trajectory reflects an unwavering pursuit of knowledge and societal impact, which makes her a deserving and inspiring nominee for the Research for Best Researcher Award.